Skip to content

Released Oct 23, 2019, after the close

10-Q filed Oct 30, 2019, 30 days after period end · 0001653477-19-000118

Q3 2019 · 10-Q
Revenue$359.90M+15.6% vs Q3 2018+2.0% vs Q2 2019
Net Income$59.90M+21.0% vs Q3 2018+5.5% vs Q2 2019
EPS Diluted$1.41+21.6% vs Q3 2018+5.2% vs Q2 2019
Gross Profit$139,500,000+17.6%
Operating Income$114,000,000+25.7%
Operating Cash Flowderived$118,700,000+24.6%
Free Cash Flowderived$96,600,000+39.8%
Margins · derived
Gross margin38.8%+0.7 pt vs Q3 2018
Operating margin31.7%+2.5 pt vs Q3 2018
Net margin16.6%+0.7 pt vs Q3 2018

What the release said

The release

Same quarter

MetricQ3 2019Q3 2018Q3 2017Q3 2016
Revenue$359.90M$311.20M$264.10M$252.40M
Net Income$59.90M$49.50M$33.80M-$7.20M
EPS Diluted$1.41$1.16$0.79-$0.17

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR